Advertisement
Canada markets open in 8 hours 16 minutes
  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CAD/USD

    0.7304
    +0.0006 (+0.09%)
     
  • CRUDE OIL

    82.94
    +0.13 (+0.16%)
     
  • Bitcoin CAD

    87,846.62
    -3,750.09 (-4.09%)
     
  • CMC Crypto 200

    1,390.39
    -33.71 (-2.37%)
     
  • GOLD FUTURES

    2,328.10
    -10.30 (-0.44%)
     
  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     
  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     
  • NASDAQ futures

    17,451.25
    -213.25 (-1.21%)
     
  • VOLATILITY

    15.97
    +0.28 (+1.78%)
     
  • FTSE

    8,040.38
    -4.43 (-0.06%)
     
  • NIKKEI 225

    37,691.12
    -768.96 (-2.00%)
     
  • CAD/EUR

    0.6818
    -0.0001 (-0.01%)
     

Stocks in play: Dollarama Inc.

Today reported increases in sales, net earnings and earnings per common share for the third quarter ended November 3, 2019. Diluted net earnings per common share rose 10.0% to $0.44. Compared to the third quarter of Fiscal 2019: Sales increased by 9.6% to $947.6 million; Gross margin was 43.7% of sales, compared to 44.3% of sales; EBITDA( grew 4.3% to $273.2 million, or 28.8% of sales, compared to 30.3% of sales; Operating income grew 3.7% to $211.9 million, or 22.4% of sales, compared to 23.6%(2) of sales; and Diluted net earnings per common share increased by 10.0%, to $0.44 from $0.40. Dollarama Inc. shares T.DOL are trading down $1.28 at $47.76.

Read: Oncolytics Biotech to Highlight Definitive Evidence of Systemic Delivery and Replication of Pelareorep in Tumor Tissue at the Fifth Annual Oncolytic Virotherapy Conference